• Users Online: 72
  • Print this page
  • Email this page


 
  Table of Contents  
MUSINGS, OPINIONS, TIPS AND EXPERIENCES
Year : 2013  |  Volume : 4  |  Issue : 1  |  Page : 52-53  

Treatment of nodular scabies with topical tacrolimus


Department of Dermatology, RNT Medical College, Udaipur, Rajasthan, India

Date of Web Publication3-Jan-2013

Correspondence Address:
Asit Mittal
House No 2, Road No. 62, Ashok Nagar, Udaipur, Rajasthan
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2229-5178.105486

Rights and Permissions

How to cite this article:
Mittal A, Garg A, Agarwal N, Gupta L, Khare AK. Treatment of nodular scabies with topical tacrolimus. Indian Dermatol Online J 2013;4:52-3

How to cite this URL:
Mittal A, Garg A, Agarwal N, Gupta L, Khare AK. Treatment of nodular scabies with topical tacrolimus. Indian Dermatol Online J [serial online] 2013 [cited 2017 Mar 24];4:52-3. Available from: http://www.idoj.in/text.asp?2013/4/1/52/105486

Nodular scabies (NS) is a well-known clinical presentation of scabies. It presents as pruritic, persistent nodules for months even after specific treatment of scabies. [1] It probably represents the hypersensitivity reaction to retained mite parts or antigens. Genital skin and scrotal skin are the commonest sites for such lesions. The treatment for these scabietic nodules can be a challenge; they are usually treated with topical steroids or with intralesional steroids but the response is less than satisfactory and relapses are frequent, also long-term use of topical corticosteroid over genital skin can lead to significant cutaneous side effects. Tacrolimus is a calcineurin inhibitor. It binds to the FK506-binding protein leading to the inhibition of calcineurin and prevention of activation of NFAT (Nuclear Factor of Activated T cells). This blocks transcription of the gene encoding IL-2 and blocks T-cell activation and further cytokine production. Also tacrolimus inhibits the release of histamine from mast cells and basophils. [2] These actions may reduce pruritus. Various reports have shown the efficacy of tacrolimus in number of inflammatory cutaneous disorders such as psoriasis, vitiligo, oral erosive lichen planus, morphea, circinate balanitis, and seborrheic dermatitis. [2] NS often shows pseudolymphoma like histopathology with predominant T lymphocytes. [1] Pimecrolimus, another calcineurin inhibitor, has already been shown to be of benefit in NS. [3] This led us to try topical tacrolimus as a therapeutic option in NS.

Ten patients of NS were chosen. All had been adequately treated for scabies with topical permethrin and were left with persistent itchy nodular lesions on scrotal and genital skin [Figure 1] and [Figure 2]. Patients were asked to apply tacrolimus 0.03% ointment twice daily over the nodular lesions for 2 weeks. No other form of topical or systemic therapy was allowed. They were followed at weekly interval. Complete disappearance of nodular lesions with significant reduction in itching was noticed in almost all cases after 2 weeks [Figure 3] and [Figure 4]. After stopping treatment, there was recurrence of lesions in almost all patients but the lesions were smaller in size and itching was much less. A repeat course of topical tacrolimus was given for 1 week and lesions disappeared again. No further follow-up was done. Except mild burning reported by few patients, topical tacrolimus was tolerated well.
Figure 1: Scabietic nodules on glans

Click here to view
Figure 2: Scabietic nodules on scrotum

Click here to view
Figure 3: After treatment with tacrolimus

Click here to view
Figure 4: After treatment with tacrolimus

Click here to view


Scabietic nodules can be a real nuisance for the practitioners. Results obtained here suggest that topical tacrolimus can be a useful option in their effective management.

 
   References Top

1.Kerl H, Ackerman AB. Inflammatory diseases that simulate lymphomas : c0 utaneous pseuolymphomas. In: Fitzpatricks TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, editors. Dermatology in General Medicine. 4 th ed. New York: McGraw-Hill Inc.; 1993. p. 1322-3.  Back to cited text no. 1
    
2.Lin AN. Topical calcineurin inhibitors. In: Wolverton SE, editor. Comprehensive Dermatologic Drug Therapy. 2 nd ed. China: Saunders Elsevier; 2007. p. 671-89.  Back to cited text no. 2
    
3.Almeida HL Jr. Treatment of steroid-resistant nodular scabies with topical pimecrolimus. J Am Acad Dermatol 2005;53:357-8.  Back to cited text no. 3
[PUBMED]    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4]


This article has been cited by
1 Mass Drug Administration for Scabies Control in a Population with Endemic Disease
Lucia Romani,Margot J. Whitfeld,Josefa Koroivueta,Mike Kama,Handan Wand,Lisi Tikoduadua,Meciusela Tuicakau,Aminiasi Koroi,Ross Andrews,John M. Kaldor,Andrew C. Steer
New England Journal of Medicine. 2015; 373(24): 2305
[Pubmed] | [DOI]
2 Nodular scabies: a classical case report in an adolescent boy
Damodara Ramachandra Reddy,Prathap Ramachandra Reddy
Journal of Parasitic Diseases. 2013;
[Pubmed] | [DOI]



 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References
    Article Figures

 Article Access Statistics
    Viewed9703    
    Printed73    
    Emailed1    
    PDF Downloaded732    
    Comments [Add]    
    Cited by others 2    

Recommend this journal